Midterm Results of Endovascular Treatment for the Patients with Thoracoabdominal Aortic Aneurysms

Yuji Kanaoka; Takao Ohki

doi:10.3400/avd.ra.19-00039

Midterm Results of Endovascular Treatment for the Patients with Thoracoabdominal Aortic Aneurysms

Ann Vasc Dis. 2019 Jun 25;12(2):163-170. doi: 10.3400/avd.ra.19-00039.

Authors

Yuji Kanaoka¹, Takao Ohki¹

Affiliation

¹ Division of Vascular Surgery, Department of Surgery, Jikei University School of Medicine, Tokyo, Japan.

Abstract

Treatment of thoracoabdominal aortic aneurysm (TAAA) remains a challenging pathology. Technologies and innovations of endovascular treatment, in particular the evolution of fenestrated and branched stent graft for complex aortic pathologies such as TAAA have provided excellent short-term results. However, the mid-term and long-term results of endovascular treatment for TAAA including endoleaks and branch patency are still unclear. This article provides an overview of available devices and results of endovascular treatment for TAAAs. (This is a translation of Jpn J Vasc Surg 2019; 28: 67-74.).

Keywords: branched endovascular aortic repair (BEVAR); fenestrated endovascular aortic repair (FEVAR); stent graft; thoracoabdominal aortic aneurysm.